Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China

Table 1 Voiding diary results at baseline vs test period in eight patients

Case	Residual urine (mL)		Average voiding volume (mL)		Maximum voiding volume (mL)		QoL score
	Baseline	Test period	Baseline	Test period	Baseline	Test period	Baseline	Test period
1	250	200	50	70	70	100	5	5
2	200	100	80	100	100	150	5	4
3	300	250	60	100	80	150	5	5
4	50	30	70	100	100	150	6	5
5	150	130	50	90	80	120	5	5
6	60	50	150	140	200	200	4	4
7	250	250	120	130	150	150	4	4
8	100	100	170	170	200	200	4	4

QoL: Quality of life.

Table 2 Voiding diary results at baseline vs test period in 46 patients

	Baseline	Test period	P value	Z value
Residual urine (mL)	60 (0-200)	15 (0-82.5)	< 0.01	-4.03
Voiding frequency	13.74 ± 5.85	9.32 ± 2.73	< 0.01
Average voiding volume (mL)	114.84 ± 53.23	184.35 ± 55.31	< 0.01
Maximum voiding volume (mL)	160 (120-200)	260 (200-300)	< 0.01	-5.1
Nocturia	3 (2-5)	2 (1-3)	< 0.01	-4.67
Urgency score	3 (0-4)	2 (0-2)	< 0.01	-4.2
QoL score	5 (3.25-5)	3.5 (3-4)	< 0.05	-1.98

Data are presented as median (interquartile range) or mean ± SD. QoL: Quality of life.

Table 3 Voiding diary results in the test period vs the latest follow-up time in 46 patients

	Test period	The latest follow-up time	P value	Z value
Residual urine (mL)	15 (0-82.5)	0 (0-70)	< 0.01	-3.28
Voiding frequency	10 (7-10)	8.5 (6.75-10)	> 0.05	-1.68
Average voiding volume (mL)	190 (150-210)	200 (155-240)	> 0.05	-0.98
Maximum voiding volume (mL)	260 (200-300)	255 (220-300)	> 0.05	-0.72
Nocturia	2 (1-3)	2 (1-2.63)	> 0.05	-0.03
Urgency score	2 (0-2)	2 (0-2)	< 0.05	-2.23
QoL score	3.5 (3-4)	4 (2-5)	> 0.05	-1.08

Data are presented as median (interquartile range). QoL: Quality of life.